共 37 条
[11]
Myeloma cells induce imbalance in the osteoprotegerin/osteoprotegerin ligand system in the human bone marrow environment. Giuliani N,Bataille R,Mancini C, et al. Blood . 2001
[12]
Regulation of osteoprotegerin mRNA levels by prostaglandin E2 in human bone marrow stroma cells. Brandstrom H,Jonsson KB,Ohlsson C, et al. Biochem Biophys Res Commun . 1998
[13]
Osteoprotegerin is bound, internalized and degraded by multiple myeloma cells. Standal T,Seidel C,Hjertner O, et al. Blood . 2002
[14]
Bone[P]. BIRL JOSEPH J.中国专利:US2436283A,1948-02-17
[15]
The effect of a single dose of osteoprotegerin in postmenopausal women. Bekker PJ,Holloway D,Nakanishi A,et al. J Bone Miner Res . 2001
[16]
Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Bucay N,Sarosi I,Dunstan CR, et al. Genes Dev . 1998
[17]
Stimulation of osteoprotegerin ( OPG) gene expression by transforming growth factor-beta (TGF-beta Mapping of the OPG promoter region that mediates TGF-beta effects. Thirunavukkarasu K,Miles RR,Halladay DL,et al. J Biol Chem . 2001
[18]
Nitric oxide donor increases osteoprotegerin production and osteoclastogenesis inhibitory activity in bone marrow stromal cells from ovariectomized rats. Wang FS,Wang CJ,Chen YJ, et al. Endocrinology . 2004
[19]
Osteoprotegerin, an endogenous antiosteoclast factor for protecting bone in rheumatoid arthritis. Bolon B,Shalhoub V,Kostenuik PJ, et al. Arthritis Rheum . 2002
[20]
Regulatory effects of osteoprotegerin on cellular and humoral immune responses. Stolina M,Guo J,Faggioni R, et al. Clin Immunol . 2003